1. Corrigendum to "Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017" [Atherosclerosis 290 (November 2019) 44–51]. (February 2020) Authors: Pottle, Alison; Thompson, Gilbert; Barbir, Mahmoud; Bayly, Graham; Cegla, Jaimini; Cramb, Robert; Dawson, Tina; Eatough, Ruth; Kale, Vaishali; Neuwirth, Clare; Nicholson, Kirsty; Payne, Jules; Scott, James; Soran, Handrean; Walji, Shahenaz; Watkins, Suzanne; Weedon, Hazel; Datta, Dev Borunendra Nath Journal: Atherosclerosis Issue: Volume 294(2020) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes. Issue 1 (November 2015) Authors: Thompson, Gilbert R.; Seed, Mary; Naoumova, Rossi P.; Neuwirth, Clare; Walji, Shahenaz; Aitman, Timothy J.; Scott, James; Myant, Nicolas B.; Soutar, Anne K. Journal: Atherosclerosis Issue: Volume 243:Issue 1(2015) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes. Issue 1 (November 2015) Authors: Thompson, Gilbert R.; Seed, Mary; Naoumova, Rossi P.; Neuwirth, Clare; Walji, Shahenaz; Aitman, Timothy J.; Scott, James; Myant, Nicolas B.; Soutar, Anne K. Journal: Atherosclerosis Issue: Volume 243:Issue 1(2015) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lipid lowering with inclisiran: a real-world single-centre experience. Issue 2 (13th December 2022) Authors: Padam, Pritpal; Barton, Lucy; Wilson, Stewart; David, Alessia; Walji, Shahenaz; de Lorenzo, Ferruccio; Ray, Kausik K; Jones, Ben; Cegla, Jaimini Journal: Open heart Issue: Volume 9:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017. (November 2019) Authors: Pottle, Alison; Thompson, Gilbert; Barbir, Mahmoud; Bayly, Graham; Cegla, Jaimini; Cramb, Robert; Dawson, Tina; Eatough, Ruth; Kale, Vaishali; Neuwirth, Clare; Nicholson, Kirsty; Payne, Jules; Scott, James; Soran, Handrean; Walji, Shahenaz; Watkins, Suzanne; Weedon, Hazel; Nath Datta, Dev Borunendra Journal: Atherosclerosis Issue: Volume 290(2019) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lipoprotein apheresis for the treatment of familial hypercholesterolemia. (October 2013) Authors: Walji, Shahenaz; Neuwirth, Clare; Thompson, Gilbert R Journal: Clinical lipidology Issue: Volume 8:Number 5(2013) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PCSK9 inhibition: "real world" experience from the hammersmith hospital lipid clinic, London. (August 2017) Authors: Cegla, Jaimini; Walji, Shahenaz; Jones, Ben; Scott, James Journal: Atherosclerosis Issue: Volume 263(2017) Page Start: e244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗